How to appeal a UnitedHealthcare substance use disorder treatment (sud/moud) denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

UnitedHealthcare-specific note: UHC's parent UnitedHealth Group owns Optum (PBM Optum Rx) and Surest. Surest plans have different cost-sharing rules. State complaints flow to state insurance department + DOL/EBSA for self-funded.

What UnitedHealthcare's policy requires for substance use disorder treatment (sud/moud)

Cited policy: Optum Behavioral Health LOC Guidelines (post-Wit) + UHC Sublocade/Brixadi MA Drug Policy

ASAM 4e + Optum BH guidelines. Sublocade typically requires 7+ days sublingual stabilization.

How UnitedHealthcare denies substance use disorder treatment (sud/moud) — and how to counter it

Where UnitedHealthcare pushes back: 1) Sublocade step therapy through SL buprenorphine first; 2) Residential SUD denied as 'outpatient sufficient'; 3) LOS limits at residential — concurrent review denials after 14-21 days.

Counter-arguments that hold up: ASAM 4e Dim-by-Dim assessment justifying 3.5/3.7 (especially Dim 5 + Dim 6). MHPAEA 2024 NQTL rule: demand UHC's comparative analysis showing residential SUD step-edits are no more stringent than medical/surgical inpatient rehab. Sublocade step: prior bupe non-adherence, diversion, prior overdose, pregnancy per ASAM NPG OUD 2020. Cite Sordo 2017 mortality data + Haight 2019 HOFER pivotal.

What UnitedHealthcare typically denies for substance use disorder treatment (sud/moud)

Across UnitedHealthcare's commercial and Medicare books, denials cluster around a small number of patterns. For substance use disorder treatment (sud/moud), expect:

• GLP-1 weight-loss exclusion
• Out-of-network reduction citing UCR
• Step therapy on biologics
• Prior auth denied for advanced imaging
• Quantity limits on specialty drugs

Treatments most often denied in this category

These are the substance use disorder treatment (sud/moud) treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Suboxone (subli)
• Sublocade LA
• Brixadi LA
• Methadone OTP
• Vivitrol LA
• Naltrexone PO

How to submit the appeal to UnitedHealthcare

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document UnitedHealthcare cited in the denial.
3. File the appeal through UnitedHealthcare's portal (members: https://www.myuhc.com ; providers: https://www.uhcprovider.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MN, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See UnitedHealthcare's prior-authorization criteria by drug: UnitedHealthcare PA criteria on ApprovalHelp.